HKG | Jotup

EpiMedTech Global to Present Revolutionary Epigenetics Research at MedInvest Biotech & Pharma Investor Conference

Retrieved on:

Tuesday, April 2, 2024

Conference, Gene expression, Syndrome, FRSC, DNA, Cancer, DNA methylation, Embryo, FCAHS, HKG, Ageing, Vaccine

The presentation will spotlight groundbreaking advancements in DNA methylation and its significant potential in transforming global healthcare through early disease detection.

Key Points:

The presentation will spotlight groundbreaking advancements in DNA methylation and its significant potential in transforming global healthcare through early disease detection.
DNA methylation, a critical process in epigenetic signaling, acts as a sophisticated regulatory mechanism, controlling gene expression without altering the DNA sequence itself.
"EpiMedTech Global is at the forefront of leveraging DNA methylation for early disease detection, aiming to bridge the vast gap between the potential of epigenetic research and its current clinical application," said Prof. Szyf.
Join us at MedInvest to discover how EpiMedTech Global is paving the way for a future where early detection and prevention are within reach for everyone, everywhere.

Meituan Announces Financial Results for the Year Ended December 31, 2023

Retrieved on:

Friday, March 22, 2024

Everyday low price, Employment, Season, Growth, Environment, Operating cost, Food, City, Treasury, Ecosystem, HKG, Marketing, GTV, Core, Health, Meal, Retail

Meanwhile, the operating loss for our New initiatives segment narrowed to RMB20.2 billion in 2023 from RMB28.4 billion in 2022.

Key Points:

Meanwhile, the operating loss for our New initiatives segment narrowed to RMB20.2 billion in 2023 from RMB28.4 billion in 2022.
For the fourth quarter of 2023, segment revenue increased by 26.8% year over year to RMB55.1 billion.
Meituan Instashopping posted another stellar growth with order volume increasing by over 40% year over year in 2023.
For the full announcement of Meituan for the year ended December 31, 2023, please visit: https://media-meituan.todayir.com/20240322164002157811109781_en.pdf

Sinopec's West Sichuan Gas Field Enters Operation

Retrieved on:

Thursday, March 14, 2024

Natural gas, Permeability, Carbon, Safety, Sichuan Basin, HKG, Porosity, Petroleum

BEIJING, March 14, 2024 /PRNewswire/ -- China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec") has announced that the West Sichuan Gas Field, Sinopec's third 100-billion-cubic-meter submarine natural gas field in the Sichuan basin, has been completed, marking another major milestone for its Project Deep Earth – Sichuan and Chongqing Natural Gas Base. The new gas field, with an annual output of 2 billion cubic meters of natural gas and 130,000 tons of sulfur, is set to provide more clean energy for Southwestern China and the regions along the Sichuan-East pipeline.

Key Points:

Boasts Over 100 Billion Cubic Meters Capacity, Enhances Southwestern China's Clean Energy Supply
BEIJING, March 14, 2024 /PRNewswire/ -- China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec") has announced that the West Sichuan Gas Field, Sinopec's third 100-billion-cubic-meter submarine natural gas field in the Sichuan basin, has been completed, marking another major milestone for its Project Deep Earth – Sichuan and Chongqing Natural Gas Base.
Sinopec overcame challenges such as low porosity and permeability in the West Sichuan Gas Field by pioneering engineering solutions, resulting in high yields with fewer wells.
The West Sichuan Gas Field, designed and built by Sinopec, features integrated gas extraction and desulfurization processes, ensuring closed-loop desulfurization and efficient green production.
The gas field boasts natural gas sulfur recovery rates of over 99.9% and produces gas that meets national standards while ensuring zero wastewater discharge.

Sinopec's West Sichuan Gas Field Enters Operation

Retrieved on:

Thursday, March 14, 2024

Natural gas, Permeability, Carbon, Safety, Sichuan Basin, HKG, Porosity, Multimedia, Petroleum

BEIJING, March 14, 2024 /PRNewswire/ -- China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec") has announced that the West Sichuan Gas Field, Sinopec's third 100-billion-cubic-meter submarine natural gas field in the Sichuan basin, has been completed, marking another major milestone for its Project Deep Earth – Sichuan and Chongqing Natural Gas Base. The new gas field, with an annual output of 2 billion cubic meters of natural gas and 130,000 tons of sulfur, is set to provide more clean energy for Southwestern China and the regions along the Sichuan-East pipeline.

Key Points:

Boasts Over 100 Billion Cubic Meters Capacity, Enhances Southwestern China's Clean Energy Supply
BEIJING, March 14, 2024 /PRNewswire/ -- China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec") has announced that the West Sichuan Gas Field, Sinopec's third 100-billion-cubic-meter submarine natural gas field in the Sichuan basin, has been completed, marking another major milestone for its Project Deep Earth – Sichuan and Chongqing Natural Gas Base.
Sinopec overcame challenges such as low porosity and permeability in the West Sichuan Gas Field by pioneering engineering solutions, resulting in high yields with fewer wells.
The West Sichuan Gas Field, designed and built by Sinopec, features integrated gas extraction and desulfurization processes, ensuring closed-loop desulfurization and efficient green production.
The gas field boasts natural gas sulfur recovery rates of over 99.9% and produces gas that meets national standards while ensuring zero wastewater discharge.

HKG EPITHERAPEUTICS RECEIVES ACCREDITATION FROM COLLEGE OF AMERICAN PATHOLOGISTS

Retrieved on:

Wednesday, January 17, 2024

Patient, Health, HKG, Cancer, Risk, Accreditation, Laboratory, CAP, Doctor of Philosophy, College, Ageing

HONG KONG, Jan. 17, 2024 /PRNewswire/ -- HKG Epitherapeutics ("HKG" or "the Company), a commercial-stage biotech company developing novel tools for the early detection of cancer and promoting healthy aging, has received renewed accreditation from the College of American Pathologists (CAP).

Key Points:

HONG KONG, Jan. 17, 2024 /PRNewswire/ -- HKG Epitherapeutics ("HKG" or "the Company), a commercial-stage biotech company developing novel tools for the early detection of cancer and promoting healthy aging, has received renewed accreditation from the College of American Pathologists (CAP).
The renewal was awarded to HKG based on results of a recent on-site inspection as part of the CAP's Accreditation Programs.
Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved patient outcomes.
"Securing the renewal of our CAP accreditation was a top priority for our laboratory," said Moshe Szyf, PhD, Founder and CEO of HKG.

HKG Epitherapeutics Announces Patent Awarded in Australia

Retrieved on:

Monday, December 18, 2023

HONG KONG, Dec. 18, 2023 /PRNewswire/ -- HKG Epitherapeutics ("HKG" or the "Company"), a commercial-stage biotech company developing novel tools for the early detection of cancer and promoting healthy aging, announced today that it has received a notice of acceptance for its patent application for DNA methylation markers for noninvasive cancer detection and uses thereof from IP Australia, the Australian government agency that administers intellectual property (IP) rights and legislation relating to patents.

Key Points:

"Cancer is the second leading cause of death globally, and its incidence rate has only been growing in Australia," said Moshe Szyf, PhD, Founder and CEO, HKG Epitherapeutics.
"As a longtime patent attorney, I believe this achievement serves as a positive indication that HKG will secure patents in additional countries where it seeks protection for its unique technology," added France Côté, Patent Agent and Co-Founder, Benoît & Côté .
"Australia can be a challenging market to receive patent approval in; however, with this recent acceptance, we are more confident than ever in our joint ability to navigate other jurisdictions successfully."
This patent application will be the first to be granted within a patent family filed in several countries.

Sinopec Highlights CCUS Achievements at COP 28 and Releases Its First 10-Year Performance Report on Supporting "Belt and Road" Initiative

Retrieved on:

Tuesday, December 12, 2023

Carbon, Belt, Sinopec, CCUS, COP28, Climate, Shell, CO2, Nature, HKG, BASF, Memorandum of understanding, Conference, Tree, Biodiversity, Utilization, Renewable energy, BRI

In 2022, Sinopec officially started to operate the mega-tonne Qilu-Shengli CCUS project, a milestone for China's CCUS industry phasing in mature commercial operation.

Key Points:

In 2022, Sinopec officially started to operate the mega-tonne Qilu-Shengli CCUS project, a milestone for China's CCUS industry phasing in mature commercial operation.
It is China's first mega-tonne CCUS demonstration project and is estimated to reduce carbon emissions by 1 million tonnes per year, the equivalent of planting nearly 9 million trees.
The project is of great significance to establishing the "artificial carbon cycle" and provides extensive practical engineering experience and technical data for large-scale CCUS project in China.
The 10-year performance report on Sinopec's engagement in BRI development underscores Sinopec's strong commitment to sustainable development and contributions, covering the scopes of energy cooperation, environmental protection, culture exchanges, and social well-being.

Sinopec Highlights CCUS Achievements at COP 28 and Releases Its First 10-Year Performance Report on Supporting "Belt and Road" Initiative

Retrieved on:

Friday, December 8, 2023

Carbon, Belt, Sinopec, CCUS, COP28, Climate, Shell, CO2, Petroleum, Nature, HKG, BASF, Memorandum of understanding, Conference, Tree, Biodiversity, Utilization, Renewable energy, BRI

In 2022, Sinopec officially started to operate the mega-tonne Qilu-Shengli CCUS project, a milestone for China's CCUS industry phasing in mature commercial operation.

Key Points:

In 2022, Sinopec officially started to operate the mega-tonne Qilu-Shengli CCUS project, a milestone for China's CCUS industry phasing in mature commercial operation.
It is China's first mega-tonne CCUS demonstration project and is estimated to reduce carbon emissions by 1 million tonnes per year, the equivalent of planting nearly 9 million trees.
The project is of great significance to establishing the "artificial carbon cycle" and provides extensive practical engineering experience and technical data for large-scale CCUS project in China.
The 10-year performance report on Sinopec's engagement in BRI development underscores Sinopec's strong commitment to sustainable development and contributions, covering the scopes of energy cooperation, environmental protection, culture exchanges, and social well-being.

Sinopec Highlights CCUS Achievements at COP 28 and Releases Its First 10-Year Performance Report on Supporting "Belt and Road" Initiative

Retrieved on:

Friday, December 8, 2023

Carbon, Belt, Sinopec, CCUS, COP28, Climate, Shell, CO2, Petroleum, Multimedia, Nature, HKG, BASF, Memorandum of understanding, Conference, Tree, Biodiversity, Utilization, Renewable energy, BRI

In 2022, Sinopec officially started to operate the mega-tonne Qilu-Shengli CCUS project, a milestone for China's CCUS industry phasing in mature commercial operation.

Key Points:

In 2022, Sinopec officially started to operate the mega-tonne Qilu-Shengli CCUS project, a milestone for China's CCUS industry phasing in mature commercial operation.
It is China's first mega-tonne CCUS demonstration project and is estimated to reduce carbon emissions by 1 million tonnes per year, the equivalent of planting nearly 9 million trees.
The project is of great significance to establishing the "artificial carbon cycle" and provides extensive practical engineering experience and technical data for large-scale CCUS project in China.
The report also highlights Sinopec's path of promoting harmonious coexistence between human beings and nature, actively advancing green and clean production, developing a circular economy, conserving biodiversity, and taking proactive climate actions.

Meituan Announces Financial Results for the Three Months Ended September 30, 2023

Retrieved on:

Tuesday, November 28, 2023

HONG KONG, Nov. 28, 2023 /PRNewswire/ -- Meituan (HKG: 3690) (the "Company"), a leading technology-driven retail company in China, today announced the unaudited consolidated results of the Company for the three months ended September 30, 2023.

Key Points:

HONG KONG, Nov. 28, 2023 /PRNewswire/ -- Meituan (HKG: 3690) (the "Company"), a leading technology-driven retail company in China, today announced the unaudited consolidated results of the Company for the three months ended September 30, 2023.
Meituan CFO Shaohui Chen said, "During the quarter, our businesses delivered resilient growth, setting new records across multiple performance metrics.
For the third quarter of 2023, segment revenue increased by 24.5% year over year to RMB57.7 billion.
For the full announcement of Meituan for the three months ended September 30, 2023, please visit: http://media-meituan.todayir.com/20231128164002589810981797_en.pdf